Reduced Volume and Faster Infusion Rate of Activated Prothrombin Complex Concentrate: A Phase 3b/4 Trial in Adults with Hemophilia A with Inhibitors
Background Activated prothrombin complex concentrate (aPCC) is indicated for bleed treatment and prevention in patients with hemophilia with inhibitors. The safety and tolerability of intravenous aPCC at a reduced volume and faster infusion rates were evaluated.
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Georg Thieme Verlag KG
2024-07-01
|
| Seri Bilgileri: | TH Open |
| Konular: | |
| Online Erişim: | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0044-1787781 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|